Iterum Secures $65 Million in Series B Financing Funding to support the Phase 3 clinical development of oral penem antibiotic DUBLIN, IRELAND, and CHICAGO –May 19, 2017 – Iterum Therapeutics Limited, an Irish clinical-stage pharmaceutical company focused on the...
Truveris selected by New Jersey to implement reverse auction and price transparency platform for pharmaceutical benefits Apr 28, 2017 Truveris will use our innovative, proprietary technology to measure the value of New Jersey’s public employee benefits contracts. The...
Banner Health Selects Kyruus for Its Patient Access and Provider Data Management Solutions by Kyruus, on Apr 11, 2017 9:03:00 AM The Deployment of ProviderMatch Throughout the System’s Call Centers and Websites Will Enhance Patient-Provider Matching Across the Network...
Deciphera Pharmaceuticals Initiates a Phase 1 Clinical Trial of DCC-3014 Waltham, MA | March 6, 2017 DCC-3014 – A Highly-Selective Small Molecule CSF1R Immunokinase Inhibitor with Potent Macrophage Checkpoint Inhibition Activity Deciphera Pharmaceuticals, a...
Mercy Health and Kyruus Forge Strategic Partnership to Further Enterprise-Wide Patient Access by Kyruus, on Feb 17, 2017 9:20:00 AM BOSTON, MA – Kyruus, a leader in provider search and scheduling solutions for health systems, announced today that Mercy Health (based...
TigerText Launches Role-based Scheduling Automation Feb 16, 2017 TigerText Automated role assignments and dynamic scheduling speed clinical communication among teams, enabling faster shift transitions and patient handoffs Power of Role-based Scheduling showcased...
Recent Comments